Clinical Trials Browser

Nonseminomatous germ cell tumor × cabozantinib × 90 days × Clear all

NCT04876456 2026-01-15

A Phase II Trial of Cabozantinib With Patients With Refractory GCTs

Phase 2 Active not recruiting

Nonseminomatous germ cell tumor, Neoplasms, Germ Cell and Embryonal, Seminoma